Public Release: 

International forum showcases QUT biotech research

Queensland University of Technology

QUT is leading new genetic research that aims to provide a food boost for livestock without relying on nutritional supplements.

Associate Professor of microbial biotechnology Robert Speight from QUT's Science and Engineering Faculty will conduct the study in collaboration with scientists from Scottish biotech company Ingenza Limited.

Associate Professor Speight said the project would demonstrate a new application of a revolutionary gene editing technique called CRISPR-Cas9 .

The method involves making precise, targeted changes to the genome of living cells.

"The advantage of the technique is the speed, accuracy and adaptability it can achieve in specific genome editing that doesn't lead to unwanted changes to the genome or addition of unnecessary foreign DNA," he said.

Associate Professor Speight said a problem faced by the agricultural feed industry was the need to add enzyme supplements to aid digestion and reduce anti-nutritional factors as well as a requirement to provide additional protein.

He said, for example, yeast was commonly used as a source of protein in feed for livestock that is added separately to enzymes that help in the digestive process.

"This project involves generating specific 'advantaged' yeast that combine both the required protein with a boost in digestive enzyme in one go," he said.

"As a result, it could then be fed to livestock not only as a source of protein but to also help feed digestion and nutrient uptake."

He said by extending the range of enzymes this technology could apply to it had wider implications for farmers as they struggled to feed their livestock in drought conditions.

"By developing an enhanced feed for livestock it will reduce costs and improve on-farm profitability," he said.

The project is supported by Scottish-based biotechnology company Ingenza Limited which has a customer base across the chemicals, pharmaceuticals, and food, feed and fuel industries.

Associate Professor Speight will present his research as part of a panel at the World Congress on Industrial Biotechnology in Montreal on July 20.


A video to explain CRISPR-Cas9 is available here

Associate Professor Robert Speight obtained a first-class degree in chemistry from Imperial College, London in 1996 before completing his PhD at the University of Cambridge.

He took up his position at QUT in August 2014 to focus on enzyme engineering and protein production systems for industrial biotechnology applications.

Media contacts:

Debra Nowland, QUT Media Officer, (Mon, Wed, Thurs) + 61 7 3138 1150

After hours, Rose Trapnell, QUT Media team leader, +61 407 585 901,

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.